000 01506 a2200409 4500
005 20250513083630.0
264 0 _c19960206
008 199602s 0 0 eng d
022 _a0305-7453
024 7 _a10.1093/jac/36.1.259
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEllis-Pegler, R B
245 0 0 _aA placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_cJul 1995
300 _a259-63 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnti-Infective Agents
_xadverse effects
650 0 4 _aCampylobacter
_xdrug effects
650 0 4 _aCampylobacter Infections
_xdrug therapy
650 0 4 _aCommunity-Acquired Infections
_xdrug therapy
650 0 4 _aDiarrhea
_xdrug therapy
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Resistance, Microbial
650 0 4 _aFeces
_xcytology
650 0 4 _aFemale
650 0 4 _aFluoroquinolones
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aQuinolones
_xadverse effects
700 1 _aHyman, L K
700 1 _aIngram, R J
700 1 _aMcCarthy, M
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 36
_gno. 1
_gp. 259-63
856 4 0 _uhttps://doi.org/10.1093/jac/36.1.259
_zAvailable from publisher's website
999 _c8536380
_d8536380